RFP
PCRX icon

Root Financial Partners’s Pacira BioSciences PCRX Stock Holding History

Root Financial Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362 Buy
+16
New +$356 ﹤0.01% 2975

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Root Financial Partners's PCRX Position: Q1 2026 in Review

Root Financial Partners opened a new position in Pacira BioSciences (PCRX) in Q1 2026: 16 shares worth $362. The stake represents ﹤0.01% of the portfolio and ranks #2975 among its holdings.

241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Root Financial Partners held 16 shares of Pacira BioSciences worth $362 as of Q1 2026.
  • Pacira BioSciences was a new Root Financial Partners position in Q1 2026.
  • Pacira BioSciences made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2975 holding.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.